Back to MW MARSHALL WACE, LLP

HBIOHBIO
16 quarters

Position history for MWMARSHALL WACE, LLP's holdings in HARVARD BIOSCIENCE INC

MARSHALL WACE, LLP previously held 0 shares of HBIO (HARVARD BIOSCIENCE INC), worth $0 as of 2025-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$40,000

Total Shares Change

-12,454

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$4.40
0
2025-Q2
New
138,700
-
$61,0280.0%$4.40
29
2023-Q3
Exited
0
-100.0%
$00.0%$43.00
0
2023-Q2
New
54,645
-
$300,0010.0%$54.90
32
2022-Q4
Exited
0
-100.0%
$00.0%$27.70
0
2022-Q3
Increased
76,923
+44.1%
$196,0000.0%$25.60
31
2022-Q2
New
53,365
-
$192,0000.0%$36.00
31
2021-Q3
Exited
0
-100.0%
$00.0%$69.80
0
2021-Q2
Increased
29,280
+10.1%
$244,0000.0%$83.30
25
2021-Q1
New
26,604
-
$145,0000.0%$54.60
31
2020-Q1
Exited
0
-100.0%
$00.0%$22.10
0
2019-Q4
Decreased
142,138
-56.3%
$434,0000.0%$30.50
0
2019-Q3
Decreased
325,448
-21.2%
$1M0.0%$30.80
0
2019-Q2
Increased
412,848
+138.5%
$826,0000.0%$20.00
40
2019-Q1
Increased
173,086
+1289.8%
$746,0000.0%$43.10
40
2018-Q4
New
12,454
-
$40,0000.0%$31.80
28

Other major holders of HBIO: BNP PARIBAS FINANCIAL MARKETS, ROYCE & ASSOCIATES LP, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used